CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-19 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $19.98 | $200K | 161,911 |
| 2023-09-19 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −10,000 | $39.10 | $391K | 151,911 |
| 2023-09-19 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | 51,099 | ||
| 2023-08-31 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +10,000 | $13.87 | $139K | 633,666 |
| 2023-08-31 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $42.82 | $428K | 623,666 |
| 2023-08-31 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 110,000 |
| 2023-08-30 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +10,000 | $13.87 | $139K | 633,666 |
| 2023-08-30 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $42.85 | $429K | 623,666 |
| 2023-08-30 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 120,000 |
| 2023-08-29 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +10,000 | $13.87 | $139K | 633,666 |
| 2023-08-29 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $42.40 | $424K | 623,666 |
| 2023-08-29 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 130,000 |
| 2023-08-22 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +1,925 | $18.41 | $35K | 153,836 |
| 2023-08-22 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −1,925 | $42.41 | $82K | 151,911 |
| 2023-08-22 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +8,075 | $19.98 | $161K | 159,986 |
| 2023-08-22 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −8,075 | $42.41 | $342K | 151,911 |
| 2023-08-22 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −1,925 | 5,580 | ||
| 2023-08-22 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −8,075 | 61,099 | ||
| 2023-08-17 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +10,000 | $13.87 | $139K | 633,666 |
| 2023-08-17 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $43.18 | $432K | 623,666 |
Page 36 of 48 · 944 trades